Carbonic anhydrase VA deficiency in humans seems to be more common than other rare metabolic diseases, and early identification might allow specific treatment of hyperammonaemia and, ultimately, prevent neurological sequelae (Summar et al., 2013). The gene discussed is CA5A; the disease is hyperinsulinemic hypoglycemia, familial, 4.